JNNP podcast show

JNNP podcast

Summary: From June 2023, all our podcasts will move to https://jnnpbmj.podbean.com. You can continue with your subscription on your favourite podcast App. JNNP's ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson's disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcasts:

 April 2017: deconstructing dilemmas in Amyotrophic Lateral Sclerosis and Guillain-Barré Syndrome | File Type: audio/mpeg | Duration: 18:14

Both patient and editor's choices are discussed in this monthly episode of the JNNP podcast. The clinical care of patients with Guillain-Barré syndrome (GBS) can often be complex; a disease with a highly variable clinical course. Professor Bart Jacobs, from the Department of Neurology at Erasmus Medical Centre (Rotterdam) provides an overview of some of the dilemmas that may arise when treating patients with GBS. The full article: http://jnnp.bmj.com/content/88/4/346. In the second part of this podcast: The C9orf72 repeat expansion is reported to have a negative impact on prognosis in amyotrophic lateral sclerosis (ALS). Until now, researchers have not been able to examine the relationship between C9orf72 and factors such as age, site of onset or gender. Dr James Rooney discusses how he and colleagues examined the prognostic impact of the C9orf72 repeat expansion in more detail. The full article is available here: http://jnnp.bmj.com/content/88/4/281.1.

 Zika virus and Guillain-Barré Syndrome: what do we know? | File Type: audio/mpeg | Duration: 15:01

There is concern that, despite being a rare complication of the Zika virus, we could see a steady rise in the number of cases of Guillain-Barré Syndrome (GBS). In preparation for this, it is important that clinicians are able to appropriately identify and differentiate between Zika-associated GBS and other neurological disorders. In this podcast, Professor Antonino Uncini (University ‘G’ d’Annunzio’, Chieti, Italy) discusses Guillain-Barré Syndrome (GBS) and it’s associations with Zika virus, as well as its clinical and electrophysiological subtypes. Read the full paper by Uncini, A., Shahrizaila, N., & Kuwabara, S. here: http://jnnp.bmj.com/content/88/3/266.

 Zika virus and Guillain-Barré Syndrome: what do we know? | File Type: audio/mpeg | Duration: 15:01

There is concern that, despite being a rare complication of the Zika virus, we could see a steady rise in the number of cases of Guillain-Barré Syndrome (GBS). In preparation for this, it is important that clinicians are able to appropriately identify and differentiate between Zika-associated GBS and other neurological disorders. In this podcast, Professor Antonino Uncini (University ‘G’ d’Annunzio’, Chieti, Italy) discusses Guillain-Barré Syndrome (GBS) and it’s associations with Zika virus, as well as its clinical and electrophysiological subtypes. Read the full paper by Uncini, A., Shahrizaila, N., & Kuwabara, S. here: http://jnnp.bmj.com/content/88/3/266.

 Immunomodulatory therapy in advanced multiple sclerosis | File Type: audio/mpeg | Duration: 14:05

Could currently available immunomodulatory therapies modify disability trajectories in patients with moderately advanced and advanced multiple sclerosis (MS)? Tomas Kalincik, Department of Medicine, University of Melbourne, Australia, discusses the findings from the MSbase cohort study with Elizabeth Highton. Read the full article here: http://jnnp.bmj.com/content/88/3/196.

 Immunomodulatory therapy in advanced multiple sclerosis | File Type: audio/mpeg | Duration: 14:05

Could currently available immunomodulatory therapies modify disability trajectories in patients with moderately advanced and advanced multiple sclerosis (MS)? Tomas Kalincik, Department of Medicine, University of Melbourne, Australia, discusses the findings from the MSbase cohort study with Elizabeth Highton. Read the full article here: http://jnnp.bmj.com/content/88/3/196.

 The relationship between orthostatic hypotension and cognitive impairment in α-synucleinopathies | File Type: audio/mpeg | Duration: 11:06

Dr Mario Masellis and Dr. Sean Udow from the Sunnybrook Health Sciences Centre, University of Toronto, Canada, look at the potential association between orthostatic hypotension and cognitive impairment in α-synucleinopathies such as Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy. Read the review published by JNNP here: http://jnnp.bmj.com/content/early/2016/09/09/jnnp-2016-314123.abstract.

 The relationship between orthostatic hypotension and cognitive impairment in α-synucleinopathies | File Type: audio/mpeg | Duration: 11:06

Dr Mario Masellis and Dr. Sean Udow from the Sunnybrook Health Sciences Centre, University of Toronto, Canada, look at the potential association between orthostatic hypotension and cognitive impairment in α-synucleinopathies such as Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy. Read the review published by JNNP here: http://jnnp.bmj.com/content/early/2016/09/09/jnnp-2016-314123.abstract.

 A clinical tool for predicting survival in motor neurone disease | File Type: audio/mpeg | Duration: 8:31

Elizabeth Highton spoke to Professor Ammar Al-Chalabi from King’s College London about the development of a simple and clinically useful graphical model of predicting survival for motor neurone disease (MND) patients. Read the article here: http://jnnp.bmj.com/content/early/2016/07/26/jnnp-2015-312908.abstract

 A clinical tool for predicting survival in motor neurone disease | File Type: audio/mpeg | Duration: 8:31

Elizabeth Highton spoke to Professor Ammar Al-Chalabi from King’s College London about the development of a simple and clinically useful graphical model of predicting survival for motor neurone disease (MND) patients. Read the article here: http://jnnp.bmj.com/content/early/2016/07/26/jnnp-2015-312908.abstract

 Latitude and disease severity in Multiple Sclerosis | File Type: audio/mpeg | Duration: 11:20

Elizabeth Highton and Prof. Bruce Taylor discuss higher latitudes and its association with earlier age of onset of Multiple Sclerosis (MS). The international study, published by the JNNP, links latitude to the age at which symptoms of MS first start. Each 10ᵒ increase in latitude is associated with a 10 month earlier onset of symptoms among those of European descent. Read the full article here: https://goo.gl/BmHXFo.

 Latitude and disease severity in Multiple Sclerosis | File Type: audio/mpeg | Duration: 11:20

Elizabeth Highton and Prof. Bruce Taylor discuss higher latitudes and its association with earlier age of onset of Multiple Sclerosis (MS). The international study, published by the JNNP, links latitude to the age at which symptoms of MS first start. Each 10ᵒ increase in latitude is associated with a 10 month earlier onset of symptoms among those of European descent. Read the full article here: https://goo.gl/BmHXFo.

 Do your kids play rugby? Risks for rugby union players from repeated concussions | File Type: audio/mpeg | Duration: 17:53

Associate Editor of JNNP Alan Carson interviews Tom McMillan, Professor at the Institute for Health & Wellbeing, University of Glasgow, UK, about the paper "Long Term Health Outcomes after Exposure to Repeated Concussion in Elite Level Rugby Union Players". Despite a high number of concussions in retired male Scottish international rugby players, the researchers didn’t find differences in mental health, social or work functioning late after injury. However, subtle group differences were detected on two cognitive tests. Listen to this podcast for full details. You can access this article here: http://jnnp.bmj.com/content/early/2016/10/05/jnnp-2016-314279.full.

 Do your kids play rugby? Risks for rugby union players from repeated concussions | File Type: audio/mpeg | Duration: 17:53

Associate Editor of JNNP Alan Carson interviews Tom McMillan, Professor at the Institute for Health & Wellbeing, University of Glasgow, UK, about the paper "Long Term Health Outcomes after Exposure to Repeated Concussion in Elite Level Rugby Union Players". Despite a high number of concussions in retired male Scottish international rugby players, the researchers didn’t find differences in mental health, social or work functioning late after injury. However, subtle group differences were detected on two cognitive tests. Listen to this podcast for full details. You can access this article here: http://jnnp.bmj.com/content/early/2016/10/05/jnnp-2016-314279.full.

 Genetics and the clinical course of multiple sclerosis | File Type: audio/mpeg | Duration: 10:32

Professor Bruce Taylor and Elizabeth Highton discuss how certain genetic risk variants may predict the clinical course and progression of Multiple Sclerosis. This podcast relates to the Patient Choice paper published in the JNNP November 2016 issue and is accessible here: http://jnnp.bmj.com/content/87/11/1204.full.

 Genetics and the clinical course of multiple sclerosis | File Type: audio/mpeg | Duration: 10:32

Professor Bruce Taylor and Elizabeth Highton discuss how certain genetic risk variants may predict the clinical course and progression of Multiple Sclerosis. This podcast relates to the Patient Choice paper published in the JNNP November 2016 issue and is accessible here: http://jnnp.bmj.com/content/87/11/1204.full.

Comments

Login or signup comment.